ABC 4’s Good Morning Utah featured the 2020 Entrepreneur & Investor Summit this morning, sitting down with Keith Marmer, Executive Director of TVC at the University of Utah and the Salt Lake City Department of Economic Development’s Peter Makowski. The E&I Summit is Utah’s premier event for investment in the life sciences industry, bringing together up-and-coming companies, […]
Utah’s vibrant life sciences industry was on full display yesterday as part of the Governor’s Office of Economic Development’s “Industry Day on the Hill”. The event, held at the state capitol, provided legislators the opportunity to interact one-on-one with company exhibitors from the aerospace, life sciences and tech industries. Representing the life sciences sector were […]
In his State of the Union address February 5, President Trump highlighted a number of health policy goals, including lowering prescription drug prices. Drug pricing continues to be a priority for the Administration and a hot topic of debate for Republicans and Democrats alike. Trump specifically pledged to tackle high drug prices, increase transparency, work […]
An MOU was signed between the Hangzhou District, World Trade Center Utah and BioUtah indicating a desire to work together for the common good of all parties. […]
Game On: Groups Launch Competing Drug Pricing Ad Campaigns With prospects dim, at least in the short-term, for passage of comprehensive drug pricing legislation in Congress, some Washington observers suggest President Trump is eager to push for regulatory changes in an effort to capture the high ground on lowering prescription drug costs ahead of the […]
The Senate on Thursday passed President Trump’s United States-Mexico-Canada Agreement (USMCA) by a wide bipartisan vote of 89-10. The USMCA, which rewrites the North America Free Trade Agreement, will now be sent to the President’s desk to be signed into law. The President is expected to sign the measure next week. Both Utah Senators, Mike […]
BioUtah/TVC 2020 Entrepreneur & Investor Life Science Summit Salt Lake City, Utah – January 17, 2020 – BioUtah, Utah’s only trade association dedicated solely to the life sciences, along with the Center for Technology & Venture Commercialization at the University of Utah, today announced distinguished speakers and sessions for the 2020 Entrepreneur & Investor Life […]
Antimicrobial Resistance (AMR) is a public health crisis, but developing new classes of antibiotics to combat drug resistant bacteria is challenging on many levels. Last month, the New York Times reported on the struggles facing companies that are researching new antibiotics. In November, the Centers for Disease Control and Prevention (CDC) released a report, Antibiotic Resistance […]
Sen. Grassley Calls on Pelosi to Support His Bill Conservative Group Backs GOP Drug Pricing Alternative As we head into 2020 election season, Democrats and Republicans alike will be working to convince voters that they have the right “prescription” to lower drug costs. At present, several different approaches are circling. With the passage of H.R. […]
On December 30, the FDA issued a notice (see the FDA’s Federal Register notice) that exempts certain class I and II medical devices from 510(k) premarket notification requirements. The exemptions, some of which are limited, cover a wide range of different products, including clinical chemistry test systems, clinical laboratory instruments, clinical toxicology test systems, hematology […]
Congress returned yesterday with a number of big ticket items on their plate, including drug pricing and the U.S.-Mexico-Canada Agreement (USMCA), both of which have implications for Utah’s life sciences industry. Drug Pricing As the House of Representatives was passing the Democrat drug pricing plan, H.R. 3, the Lower Drug Prices Now Act, in the […]
SALT LAKE CITY–(BUSINESS WIRE)–BioUtah applauds congressional action to permanently repeal the 2.3% excise tax on the sale of medical devices, first enacted as part of the Affordable Care Act in 2010. Earlier in the week, the U.S. House of Representatives voted to repeal the tax as part of a $1.4 trillion FY 2020 government spending […]